Crossmark

Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia

Published Online: 2017-11-28

Published Print: 2018-01

Authors

Zanardi, Alan

Conti, Antonio

Cremonesi, Marco

D'Adamo, Patrizia

Gilberti, Enrica

Apostoli, Pietro

Cannistraci, Carlo Vittorio

Piperno, Alberto

David, Samuel

Alessio, Massimo https://orcid.org/0000-0002-4133-3472
Funding

Funding for this research was provided by:

Fondazione Telethon (GEP‐14102)
License Information

Version of Record valid from 2017-11-28
More Information

Publication History

Received: 2017-08-04

Accepted: 2017-10-30

Published: 2017-11-28

Document is current